GPT-Rosalind (OpenAI) vs Qwen (Alibaba)

Which one should you pick? Here's the full breakdown.

GPT-Rosalind (OpenAI)

C
6.8/10

OpenAI's first domain-specific model -- life sciences, drug discovery, translational medicine. Launched 2026-04-16 as a Trusted Access research preview. Launch partners: Amgen, Moderna, Allen Institute, Thermo Fisher. Paired with a Life Sciences Codex plugin (50+ scientific tool integrations)

Our Pick

Qwen (Alibaba)

A
8.8/10

Alibaba's open-weights + API family -- Qwen 3.6-Plus (Mar 30 2026, 1M context + always-on CoT + agentic tool-use), Qwen3.5 Small (2B runs on iPhone, 9B matches 120B-class models), plus Qwen3.5-Omni native multimodal. Apache 2.0 on the open sizes

CategoryGPT-Rosalind (OpenAI)Qwen (Alibaba)
Ease of Use3.07.0
Output Quality9.09.0
Value7.010.0
Features8.09.0
Overall6.88.8

Pricing Comparison

FeatureGPT-Rosalind (OpenAI)Qwen (Alibaba)
Free TierNoYes
Starting PriceInvite only$0

Benchmark Head-to-Head

Qwen3.5-397B MoE benchmarks — GPT-Rosalind (OpenAI) has no published benchmarks

BenchmarkScore
MMLU-Pro83.5%
GPQA Diamond78.2%
AIME 202587%
HumanEval92.5%
SWE-Bench Verified69.4%

Which Should You Pick?

Pick GPT-Rosalind (OpenAI) if...

Researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get Trusted Access. Also relevant to anyone building life-sciences AI products who needs to understand where OpenAI's vertical strategy is heading.

Visit GPT-Rosalind (OpenAI)

Pick Qwen (Alibaba) if...

  • Easier to use (7 vs 3)
  • Better value for money (10/10)
  • More features (9 vs 8)
  • Has a free tier

Developers who want frontier-tier open weights with Apache 2.0 licensing. Qwen3-Coder-Next is arguably the best local coding model; Qwen3.5-397B is a top-3 open generalist.

Visit Qwen (Alibaba)

Our Verdict

Qwen (Alibaba) is the clear winner here with 8.8/10 vs 6.8/10. GPT-Rosalind (OpenAI) isn't bad, but Qwen (Alibaba) outperforms it across the board. Pick GPT-Rosalind (OpenAI) only if researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get trusted access.